Edgewell Personal Care reported third quarter fiscal 2026 results with organic net sales up 1.1%, driven by a 3% increase in North America, while adjusted earnings per share of $0.72 and adjusted EBITDA of $78.9 million came in ahead of expectations. CEO Rod Little said the company expects stronger overall growth in the fourth quarter and maintained the full-year adjusted EPS and adjusted EBITDA outlook at the midpoint, with organic net sales now expected to be flat to up 50 basis points, adjusted EPS in the range of $1.80 to $2.00, and adjusted EBITDA between $250 million and $260 million. CFO Francesca Weissman noted that adjusted gross margin declined 30 basis points in the quarter, in line with expectations, and that the company expects material gross margin expansion in the fourth quarter driven by productivity savings, cycling of one-time costs, and favorable foreign exchange. During the quarter there were headlines about an unsolicited offer and that the Board had rejected the offer as insufficient, and when asked about it, Little said the company cannot comment on rumors or speculation but that the Board has a fiduciary duty and would consider any inbound proposal that beats the organic plan. International organic sales declined 1.4% due to the Middle East conflict, lower private label sales from temporary supply disruptions, and a weaker start to the sun season in Europe and Latin America, but the company expects international to return to growth in the fourth quarter.
Edgewell Personal Care CoQ3 results beat expectations and full-year outlook maintained, with stronger Q4 growth expected.
